Tirzepatide is a dual-action peptide that activates both GLP-1 and GIP receptors, making it more effective than single-receptor treatments for weight management. It represents the latest advancement in metabolic peptide research.
Category
Purity
Lab grade
Primary Research Areas
Weight management, metabolic health, blood sugar control, body composition
By proceeding, you agree to our Terms of Service and acknowledge our Research Use Policy. peptide+ reserves the right to refuse service to any individual or entity suspected of misuse.